Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

Background and purpose: Pharmacological inhibition of beta‐amyloid (Aβ) induced reactive gliosis may represent a novel rationale to develop drugs able to blunt neuronal damage and slow the course of Alzheimer's disease (AD). Cannabidiol (CBD), the main non‐psychotropic natural cannabinoid, exer...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of pharmacology 2007-08, Vol.151 (8), p.1272-1279
Hauptverfasser:	Esposito, G, Scuderi, C, Savani, C, Steardo, L, Filippis, D, Cottone, P, Iuvone, T, Cuomo, V
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences cannabidiol GFAP IL‐1β iNOS Medical sciences mice Pharmacology. Drug treatments reactive gliosis Research Papers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!